Schonfeld Strategic Advisors LLC Acquires Shares of 22,992 Option Care Health, Inc. (NASDAQ:OPCH)

Schonfeld Strategic Advisors LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 22,992 shares of the company’s stock, valued at approximately $533,000.

A number of other large investors have also recently made changes to their positions in the company. Cornerstone Investment Partners LLC lifted its stake in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the last quarter. Assetmark Inc. boosted its holdings in Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after acquiring an additional 487 shares during the period. Pacer Advisors Inc. grew its position in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after acquiring an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management increased its stake in Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after purchasing an additional 550 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by company insiders.

Option Care Health Stock Up 0.4 %

Option Care Health stock opened at $31.84 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.21 billion, a P/E ratio of 26.76, a P/E/G ratio of 2.30 and a beta of 0.76. The business has a fifty day moving average of $33.24 and a two-hundred day moving average of $28.89. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter last year, the company earned $0.26 earnings per share. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on OPCH. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reissued a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.